Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.42 USD
Change Today +0.0682 / 5.05%
Volume 18.1K
CASI On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wei-Wu He Ph.D.

Chairman of the Board,CASI Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 18 board members in 3 different organizations across 4 different industries.

See Board Relationships


Dr. Wei-Wu He, Ph.D. founded OriGene Technologies, Inc., in 1995 and serves as its Chairman and Chief Executive Officer. Dr. He is a Co-Founder and General Partner at Emerging Technology Partners, LLC. Dr. He is one of the founding investors in Intradigm. He served as Chairman and Chief Executive Officer at Cytomyx Holdings plc since November 28, 2006. He served as President of OriGene Technologies, Inc. Dr. He has been the Chairman of CASI Pharmaceuticals, Inc. since ...

Read Full Background

Corporate Headquarters*

9620 Medical Center Drive
Rockville, Maryland 20850

United States

Phone: 240-864-2600
Fax: 301-315-2437

Board Members Memberships*

Chairman and Chief Executive Officer
Chairman of the Board


University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options625,000
Total Number of Options625,000

Total Compensation*

Total Annual Cash Compensation$55,000
Total Calculated Compensation$343,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CASI:US $1.42 USD +0.0682


Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CASI PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at